BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Novavax, Inc. To Host Conference Call To Discuss Third Quarter 2014 Financial Results On November 5, 2014

  October 30, 2014

   · 

  1 min read
• Drug Development

  AnaMar AB Reports Top-Line Results From Exploratory Phase 2a Study Of AMAP102 And Provides Corporate Update

  October 30, 2014

   · 

  4 min read
• Drug Development

  Recro Pharma Announces Dosing Of First Patient In Phase 2 REC-14-013 Clinical Trial Of Dex-IN For Treatment Of Acute Pain On Day 1 Following Surgery

  October 30, 2014

   · 

  7 min read
• Lone Star Bio

  Ebola Scare Boosts Demand For Xenex Germ-Zapping Robots: CEO

  October 30, 2014

   · 

  1 min read
• Pharm Country

  Nasdaq Welcomes Sientra, Inc.To The Nasdaq Stock Market

  October 30, 2014

   · 

  3 min read
• FDA

  Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older

  October 30, 2014

   · 

  3 min read
• Business

  Accuray Inc. Reports Financial Results For First Quarter Of Fiscal Year 2015

  October 30, 2014

   · 

  9 min read
• Business

  Vision-Sciences, Inc. To Host Second Quarter Fiscal 2015 Results Call

  October 30, 2014

   · 

  1 min read
• Business

  ReWalk To Discuss Third Quarter 2014 Financial Results On November 13, 2014 Conference Call

  October 30, 2014

   · 

  1 min read
• FDA

  TWi Pharmaceuticals, Inc. Receives U.S. FDA Approval On Generic Donepezil Hydrochloride Tablets USP, 23 Mg, Its Fifth ANDA From U.S. FDA

  October 30, 2014

   · 

  1 min read